Name: Protagonist Therapeutics, Inc. (PTGX) Financial Statements
Creator: FinSpry

Protagonist Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Protagonist Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	434.43	60.00	26.58	27.36	28.63	0.06	30.93
Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	434.43	60.00	26.58	27.36	28.63	0.06	0.00
Operating Expenses
Research & Development	138.13	120.16	126.22	126.01	74.51	65.00	59.50
Selling, General & Administrative	43.46	33.49	31.74	27.20	18.64	15.75	13.70
Operating Expenses	181.59	153.65	157.95	153.20	93.14	80.75	73.19
Operating Income	252.84	-93.65	-131.37	-125.85	-64.52	-80.52	-42.27
Other Income/Expense
Interest Income	26.32	14.90	4.06	0.44	0.90	0.00	2.57
Interest Expense	0.00	0.00	0.00	0.00	-0.60	0.00	0.00
Other Income/Expense	26.57	-0.20	-0.08	-0.15	0.63	0.00	-0.02
Income
Income Before Tax	279.41	-78.96	-127.39	-125.55	-64.85	-77.88	-39.72
Income Tax Expense	4.22	0.00	0.00	0.00	1.31	-0.69	-0.80
Net Income	275.19	-78.96	-127.39	-125.55	-66.15	-77.19	-38.92
Net Income - Continuous Operations	275.19	-78.96	-127.39	-125.55	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	253.67	-90.34	-128.00	-123.07	-61.52	-75.81	-39.20
EBIT	252.84	-93.65	-131.37	-125.85	-64.25	-77.71	-39.72
Depreciation & Amortization	0.83	3.31	1.03	2.78	0.79	0.70	0.00
Earnings Per Share
Basic EPS	4.00	-1.00	-3.00	-3.00	-2.00	-3.00	-2.00
Diluted EPS	4.00	-1.00	-3.00	-3.00	-2.00	-3.00	-2.00
Basic Shares Outstanding	61.57	56.76	49.04	46.32	34.40	25.89	22.36
Diluted Shares Outstanding	65.08	56.76	49.04	46.32	34.40	25.89	22.36